747 related articles for article (PubMed ID: 17022737)
1. Cannabinoid drugs and enhancement of endocannabinoid responses: strategies for a wide array of disease states.
Karanian DA; Bahr BA
Curr Mol Med; 2006 Sep; 6(6):677-84. PubMed ID: 17022737
[TBL] [Abstract][Full Text] [Related]
2. Targeting the endocannabinoid system in treating brain disorders.
Bahr BA; Karanian DA; Makanji SS; Makriyannis A
Expert Opin Investig Drugs; 2006 Apr; 15(4):351-65. PubMed ID: 16548785
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality.
Hwang J; Adamson C; Butler D; Janero DR; Makriyannis A; Bahr BA
Life Sci; 2010 Apr; 86(15-16):615-23. PubMed ID: 19527737
[TBL] [Abstract][Full Text] [Related]
4. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
Ligresti A; Petrosino S; Di Marzo V
Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoid System: A Multi-Facet Therapeutic Target.
Kaur R; Ambwani SR; Singh S
Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoids, endocannabinoids, and cancer.
Hermanson DJ; Marnett LJ
Cancer Metastasis Rev; 2011 Dec; 30(3-4):599-612. PubMed ID: 22038019
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptors and their role in neuroprotection.
van der Stelt M; Di Marzo V
Neuromolecular Med; 2005; 7(1-2):37-50. PubMed ID: 16052037
[TBL] [Abstract][Full Text] [Related]
8. Endocannabinoid overactivity and intestinal inflammation.
Di Marzo V; Izzo AA
Gut; 2006 Oct; 55(10):1373-6. PubMed ID: 16966693
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids and the gut: new developments and emerging concepts.
Izzo AA; Sharkey KA
Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
[TBL] [Abstract][Full Text] [Related]
10. Exploration of Multiverse Activities of Endocannabinoids in Biological Systems.
Behl T; Makkar R; Sehgal A; Singh S; Makeen HA; Albratty M; Alhazmi HA; Meraya AM; Bungau S
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628545
[TBL] [Abstract][Full Text] [Related]
11. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
[TBL] [Abstract][Full Text] [Related]
12. The endocannabinoid system as a target for the treatment of neurodegenerative disease.
Scotter EL; Abood ME; Glass M
Br J Pharmacol; 2010 Jun; 160(3):480-98. PubMed ID: 20590559
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid/Endocannabinoid signaling impact on early pregnancy events.
Sun X; Dey SK
Curr Top Behav Neurosci; 2009; 1():255-73. PubMed ID: 21104387
[TBL] [Abstract][Full Text] [Related]
14. The endocannabinoid system: physiology and pharmacology.
Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoid system in neurodegenerative disorders.
Basavarajappa BS; Shivakumar M; Joshi V; Subbanna S
J Neurochem; 2017 Sep; 142(5):624-648. PubMed ID: 28608560
[TBL] [Abstract][Full Text] [Related]
16. The endocannabinoid system in neurodegeneration.
Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M
Ital J Biochem; 2006; 55(3-4):283-9. PubMed ID: 17274532
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration.
Basavarajappa BS; Nixon RA; Arancio O
Mini Rev Med Chem; 2009 Apr; 9(4):448-62. PubMed ID: 19356123
[TBL] [Abstract][Full Text] [Related]
18. The endocannabinoid signaling system: a potential target for next-generation therapeutics for alcoholism.
Basavarajappa BS
Mini Rev Med Chem; 2007 Aug; 7(8):769-79. PubMed ID: 17692039
[TBL] [Abstract][Full Text] [Related]
19. The endogenous cannabinoid system and its role in nociceptive behavior.
Cravatt BF; Lichtman AH
J Neurobiol; 2004 Oct; 61(1):149-60. PubMed ID: 15362158
[TBL] [Abstract][Full Text] [Related]
20. The endocannabinoid system in ageing: a new target for drug development.
Paradisi A; Oddi S; Maccarrone M
Curr Drug Targets; 2006 Nov; 7(11):1539-52. PubMed ID: 17100593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
